Glucotrack, Inc. Enters Material Agreement, Reports Equity Sales
Ticker: GCTK · Form: 8-K · Filed: Sep 12, 2025 · CIK: 1506983
Sentiment: neutral
Topics: material-agreement, financial-obligation, equity-sale
TL;DR
Glucotrack signed a big deal, owes money, and sold stock. Watch this.
AI Summary
On September 12, 2025, Glucotrack, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company also reported unregistered sales of equity securities. Specific details regarding the agreement and the financial obligation are not fully disclosed in this filing.
Why It Matters
This filing indicates Glucotrack, Inc. has entered into a significant agreement that creates a financial obligation and has also issued new equity, which could impact its financial structure and shareholder dilution.
Risk Assessment
Risk Level: medium — The filing mentions a material definitive agreement and a direct financial obligation, which introduces financial risk, alongside unregistered equity sales that could dilute existing shareholders.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- September 12, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement Glucotrack, Inc. entered into?
The filing states that Glucotrack, Inc. entered into a material definitive agreement on September 12, 2025, but does not provide specific details about the agreement itself.
What is the direct financial obligation created by Glucotrack, Inc.?
The filing indicates the creation of a direct financial obligation by Glucotrack, Inc. on September 12, 2025, but the specific terms and amount of this obligation are not detailed.
When did Glucotrack, Inc. file this 8-K report?
Glucotrack, Inc. filed this 8-K report on September 12, 2025.
What other significant event is reported in this filing besides the agreement?
In addition to the material definitive agreement, the filing reports unregistered sales of equity securities by Glucotrack, Inc.
What was Glucotrack, Inc.'s former name?
Glucotrack, Inc. was formerly known as GlucoTrack, Inc. until March 28, 2022, and prior to that, Integrity Applications, Inc. until December 3, 2010.
Filing Stats: 1,244 words · 5 min read · ~4 pages · Grade level 12.2 · Accepted 2025-09-12 17:29:25
Key Financial Figures
- $3,600,000 — the Investor in the principal amount of $3,600,000 for a purchase price of $3,000,000. T
- $3,000,000 — t of $3,600,000 for a purchase price of $3,000,000. The Note bears no interest, has an o
- $600,000 — rest, has an original issue discount of $600,000, is an unsecured obligation of the Comp
- $5,000,000 — oss proceeds to the Company of at least $5,000,000 (excluding indebtedness converted in su
- $0.001 — ce per share of common stock, par value $0.001 per share (the " Common Stock "), shall
- $4 — shall not, in any event, be lower than $4.87, subject to adjustment for stock spl
- $20.0 million — Borough is obligated to purchase, up to $20.0 million of the Company's Common Stock (the "Pur
Filing Documents
- form8-k.htm (8-K) — 50KB
- ex4-1.htm (EX-4.1) — 34KB
- ex10-1.htm (EX-10.1) — 91KB
- 0001493152-25-013290.txt ( ) — 365KB
- gctk-20250912.xsd (EX-101.SCH) — 3KB
- gctk-20250912_lab.xml (EX-101.LAB) — 33KB
- gctk-20250912_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 12, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer